Stock Alert: Obalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences

Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc.

OBLN is currently trading at $2.84, up $1.23 or 76.40%, on the Nasdaq.

ReShape Lifesciences, a weight-loss solutions company, entered into a merger agreement with Obalon Therapeutics, under which ReShape and Obalon will combine in an all-stock transaction.

Under the agreement, which has been unanimously approved by the boards of both companies, existing ReShape stockholders will have majority ownership of the combined company.

Obalon will be renamed ReShape Lifesciences Inc. and will trade under the NASDAQ ticker symbol "RSLS."

The current directors and officers of ReShape will comprise the board of directors and executive management of the combined company.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Apple Inc. (AAPL) jumped nearly 5% in extended trading session on Thursday after the California-based tech giant reported first-quarter results, with both earnings and revenues trumping Wall Street's expectations, driven by strong demand for its latest iPhone 13 and other services. Apple... The U.S. Food and Drug Administration has revised the authorizations for two monoclonal antibody treatments - bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) - to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments. Comcast Corp. (CMCSA, CMCSK) on Thursday reported that net income attributable to Comcast for the quarter decreased 9.6 percent to $3.06 billion or $0.66 per share from $3.38 billion or $0.73 per share in the year-ago quarter. Excluding items, adjusted earnings for the quarter were $0.77, compared to...
Follow RTT